tv003
Vaccineexperimental
Clinical trial activity
3 trials · 5 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
2
Phase 3
0
Phase 4
0
Earliest trial started Jan 1, 2013 (NCT01782300)
Timeline
Indications
Studied for
Mechanism of action
- Dengue virusImmunity, active
Dengue virus immunity, active
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- tv003
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT03485144 | Phase 2 | Dec 12, 2017 | Medigen Biotechnology Corporation, National Taiwan University |
| NCT02332733 | Phase 2 | Nov 1, 2014 | Government of Thailand, National Institute of Allergy and Infectious Diseases (NIAID) |
| NCT01782300 | Phase 1 | Jan 1, 2013 | Johns Hopkins University, National Institute of Allergy and Infectious Diseases (NIAID) |
Showing 3 of 3 trials
Page 1 / 1
Organizations
Research & Development (5)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| National Institute of Allergy and Infectious Diseases (NIAID) | Government | 2 | 2 | 2 | 2013 |
| Government of Thailand | Government | 1 | 0 | 1 | 2014 |
| Johns Hopkins University | Academic/Hospital | 1 | 0 | 1 | 2013 |
| Medigen Biotechnology Corporation | For profit | 1 | 1 | 1 | 2017 |
| National Taiwan University | Academic/Hospital | 1 | 0 | 1 | 2017 |
5 organizations
Page 1 / 1